You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
金安國紀:防風通聖丸產品列入《新型冠狀病毒的肺炎診療方案》(試行第五版)
格隆匯 02-10 17:17

格隆匯2月10日丨金安國紀(002636.SZ)公佈,2020年2月5日,國家衞生健康委和國家中醫藥管理局聯合發佈了《新型冠狀病毒感染的肺炎診療方案(試行第五版)》。公司控股子公司承德天原生產的防風通聖丸(顆粒)被該方案列為中醫治療醫院觀察期推薦用藥。

防風通聖丸(顆粒)為承德天原的現有產品、國家基本藥物目錄和國家醫保目錄(甲類)品種,主要用於外寒內熱、表裏俱實、惡寒壯熱、頭痛咽乾、小便短赤、大便祕結、瘰癧初起、風疹濕瘡等相關疾病的治療。

公司預計此次《新型冠狀病毒感染的肺炎診療方案(試行第五版)》的發佈將對防風通聖丸(顆粒)產品的市場推廣和銷售產生積極影響,提請廣大投資者注意投資風險。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account